Arena's stock surge comes after the price this year had dropped by 35%.

The agreement is an early sign that, despite the threat of close antitrust examinations and higher …

Pfizer will still benefit from the 25% stake it retained as well as full rights to the drug outside…

Pfizer is in early talks to acquire cancer drugmaker Seagen in a potentially multibillion-dollar de…

The famed investor's company spent nearly $18 billion on stocks and $9 billion on buybacks, and str…

One of the most common pharmaceutical products, Botox is currently known as an anti-wrinkle treatme…

There is, of course, no guarantee of future dealmaking, but this latest acquisition could foreshado…

"The proposed acquisition of Array strengthens our innovative biopharmaceutical business, is expect…

The deal, Pfizer's biggest since 2016, represents a big investment into finding treatments for two …

Across these deals, a common theme is that companies have been eyeing drugs with strong research da…

Treasury has taken action twice to make it harder for companies to invert. These actions took away …

Recent M&A transactions show that big pharma is betting big on gene therapy. In April, Novartis…

"In lieu of congressional action on some sort of international tax plan that would've made our tax …

"With targeted medicine, you know really quickly, and can stop the program right away" if the drug …

As in its previous proposal, Pfizer is considering a possible transaction in which AstraZeneca shar…

But now that that's been quashed, Pfizer could turn to a few other big companies both in the US and…

If the deal makes its way past shareholders and regulators, and if it doesn't run into too much tro…

Chairman Jerome Powell could speed up the taper of the Fed's monthly bond purchases and reveal when…

Fed Chairman Jerome Powell could speed up its monthly bond purchase tapering program as it seeks to…

As some high-profile SPACs have imploded or fallen afoul of regulators, investors have increasingly…